These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 36985763)
1. An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products. Kitdumrongthum S; Trachootham D Molecules; 2023 Mar; 28(6):. PubMed ID: 36985763 [TBL] [Abstract][Full Text] [Related]
2. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study. Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169 [TBL] [Abstract][Full Text] [Related]
3. Applications of Capillary Electrophoresis for the Determination of Cannabinoids in Different Matrices. Blebea NM; Hancu G; Vlad RA; Pricopie A Molecules; 2023 Jan; 28(2):. PubMed ID: 36677696 [TBL] [Abstract][Full Text] [Related]
4. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure. Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of Δ Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731 [TBL] [Abstract][Full Text] [Related]
6. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure. Pintori N; Caria F; De Luca MA; Miliano C Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982327 [TBL] [Abstract][Full Text] [Related]
7. Individual and combined effects of cannabidiol and Δ Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578 [TBL] [Abstract][Full Text] [Related]
8. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products. Nutt DJ; Phillips LD; Barnes MP; Brander B; Curran HV; Fayaz A; Finn DP; Horsted T; Moltke J; Sakal C; Sharon H; O'Sullivan SE; Williams T; Zorn G; Schlag AK Cannabis Cannabinoid Res; 2022 Aug; 7(4):482-500. PubMed ID: 33998895 [No Abstract] [Full Text] [Related]
9. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model. Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774 [TBL] [Abstract][Full Text] [Related]
10. Translational models of cannabinoid vapor exposure in laboratory animals. Moore CF; Stiltner JW; Davis CM; Weerts EM Behav Pharmacol; 2022 Apr; 33(2&3):63-89. PubMed ID: 33136615 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Legare CA; Raup-Konsavage WM; Vrana KE Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949 [TBL] [Abstract][Full Text] [Related]
12. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use. Gibson LP; Gust CJ; Ellingson JM; YorkWilliams SL; Sempio C; Klawitter J; Bryan AD; Hutchison KE; Cinnamon Bidwell L Drug Alcohol Depend; 2021 Jun; 223():108718. PubMed ID: 33866072 [TBL] [Abstract][Full Text] [Related]
13. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence. Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510 [TBL] [Abstract][Full Text] [Related]
14. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids. Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166 [TBL] [Abstract][Full Text] [Related]
15. Effects of cannabinoids on resting state functional brain connectivity: A systematic review. Lorenzetti V; Gaillard A; Thomson D; Englund A; Freeman TP Neurosci Biobehav Rev; 2023 Feb; 145():105014. PubMed ID: 36563921 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid Content in Cannabis Flowers and Homemade Cannabis-Based Products Used for Therapeutic Purposes in Argentina. Sedan D; Vaccarini C; Demetrio P; Morante M; Montiel R; Saurí A; Andrinolo D Cannabis Cannabinoid Res; 2023 Feb; 8(1):197-206. PubMed ID: 33998894 [No Abstract] [Full Text] [Related]
17. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics and the pharmacodynamics of cannabinoids. Lucas CJ; Galettis P; Schneider J Br J Clin Pharmacol; 2018 Nov; 84(11):2477-2482. PubMed ID: 30001569 [TBL] [Abstract][Full Text] [Related]
19. The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ Geci M; Scialdone M; Tishler J Cannabis Cannabinoid Res; 2023 Apr; 8(2):270-282. PubMed ID: 36264171 [No Abstract] [Full Text] [Related]
20. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]